Project Grant H79TI080690

PROTECT AL: PrEP Optimization Through Enhanced Continuum Tracking The National Institute of Mental Health awarded the University of Alabama at Birmingham a $790,198 Project Grant on September 18, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop and implement PROTECT AL, a data-driven initiative designed to optimize HIV pre-exposure prophylaxis (PrEP) utilization across Alabama's high-incidence areas. The project, extending through May 31, 2030, delivers a...

The Boys & Girls Clubs of Puerto Rico received a $972,405 Cooperative Agreement from the Department of Justice (DOJ) Office of Juvenile Justice and Delinquency Prevention (CFDA 16.818 - Children Exposed to Violence) to implement the Puerto Rico Intervention, Diversion, and Education (PRIDE) program. PRIDE supports children and youth aged 6-18 exposed to violence in two high-crime, high-poverty public housing communities in Puerto Rico. The program provides a three-tiered system of...

This $5.37 million project grant from the National Institutes of Health National Institute on Drug Abuse will fund the development of a context-aware digital adherence intervention called SMARTSTEPS to improve pre-exposure prophylaxis (PrEP) adherence among men who have sex with men with substance use disorder. The grant will support two phases. Phase I will inform the specification of an algorithm that utilizes digital phenotyping data from a smartphone app to anticipate non-adherence based...

This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...

HEP C FREE Puerto Rico Integrated Care Pilot – Award Summary Mennonite General Hospital, Inc. (MGHPR) received a $7.5 million Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243). The award, effective September 30, 2025, through September 29, 2027, funds an integrated hepatitis C (HCV) care pilot...

Federal Grant Award Summary New York Blood Center, Inc. received a $485,131 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded September 22, 2025, with a completion date of September 21, 2027. This research project investigates the influence of social networks on HIV (human immunodeficiency virus) testing and PrEP (pre-exposure prophylaxis) care utilization among young Latin American gay, bisexual, and other...

The Puerto Rican Cultural Center (PRCC) received a $400,000 Project Grant from the U.S. Department of Justice's Bureau of Justice Assistance under the Community-Based Approaches to Advancing Justice program (CFDA 16.047). The grant funding will support PRCC's work with its sub-awardee, Waves Ahead in Maunabo, Puerto Rico, to address hate crimes against the LGBTQ+ community. Key initiatives include expanding community relations, public education, and preventative measures such as restorative...

This Project Grant award of $665,225 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to improve access and adherence to Pre-Exposure Prophylaxis (PrEP) among adolescent girls and young women in Uganda. The 5-year project, titled "SUUBI4PREP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda", will combine peer support interventions with economic empowerment initiatives to address...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...

Summary Empowerx, Inc., a woman-owned small business, received a $485,654 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) on September 22, 2025, with a completion date of August 31, 2026. The award funds the PEP/PREP Via Pharmacist-Prescribing Implementation (PEPPI) project, which will develop user-informed software to support the implementation of pharmacist-prescribed post-exposure prophylaxis (PEP) and...